Contributions to Books «Previous Next»

Drug companies and Schizophrenia: Unbridled Capitalism meets Madness

L. R. Mosher
R. Gosden, University of Wollongong
S. Beder, University of Wollongong

Article comments

This book chapter was originally published as Mosher, LR, Gosden, R and Beder, S, Drug companies and Schizophrenia: Unbridled Capitalism meets Madness', in Read, J, Mosher, LR and Bentall, R (eds), Models of Madness: Psychological , Social and Biological Approaches to Schizophrenia, Brunner-Routledge, New York, 2004, 115-130. Copyright Taylor & Francis. Original book available here.

Abstract

While the major thrust of this volume is an examination of the psychosocial origins and approaches to dealing with the problem labeled as “schizophrenia” it must also provide a historical context and examine critically how the current complete domination of schizophrenia’s “treatment” by the neuroleptic drugs (we’ll use this term and antipsychotic interchangeably) came to be. Not only do they dictate practice but they also buttress the biomedical theorizing that dominates thinking about the problem.

Suggested Citation

L. R. Mosher, R. Gosden, and S. Beder. "Drug companies and Schizophrenia: Unbridled Capitalism meets Madness" Faculty of Arts - Papers. , 2004.
Available at: http://works.bepress.com/sbeder/14